RxDoctor Payments Data

Brad Laudicina, OD

Optometrist · Bradenton, FLNPI 1568719185

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $130,000 of the $169,896 with a category attached, or 76.5%. Bausch & Lomb Americas Inc. accounts for 98.6% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $100,365, more than ten times the $578 reported in 2019. Among optometrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$169,896in general payments, 2019–2025

Across 396 payments — averaging $429.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb Americas Inc.$168K
  • Alcon$483
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$348
  • Sun Pharmaceutical Industries Inc.$193
  • Sight Sciences, Inc.$150
  • Rxsight Inc$136
  • plus $1K from 12 others

What the payments were for

  • Consulting fees$1,5001%
  • Speaking & faculty fees$130,00077%
  • Travel & lodging$30,06518%
  • Food & beverage$8,3315%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$169,896 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.

See all optometrist providers in Florida

Medicare billing

Part B allowed, 2024
$34,725
Medicare patients
242
Services billed
373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost13$3,558
Latanoprost29$233
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha11$100

Paid to pharmacies, not to this prescriber.

Other optometrist in Bradenton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →